| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7K | -85.4% |
| R&D Expense | $9.7M | +51.6% |
| SG&A Expense | $21.7M | +38.3% |
| Operating Income | -$31.4M | -42.4% |
| Pre-tax Income | -$27.9M | -38.2% |
| Income Tax | -$79K | -100.5% |
| Net Income | -$27.9M | +23.1% |
| EPS (Basic) | -$7.79 | -1427.5% |
| EPS (Diluted) | -$7.79 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.3M | -69.6% |
| Accounts Receivable | $2K | -85.7% |
| Current Assets | $53.8M | -64.6% |
| Total Assets | $60.4M | -60.5% |
| Current Liabilities | $1.3M | +71.5% |
| Total Liabilities | $4.4M | +501.8% |
| Stockholders' Equity | $56.0M | -63.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.8M | -46.6% |
| Capital Expenditures | $65K | — |
| Investing Cash Flow | $35.9M | +193.3% |
| Financing Cash Flow | -$71.4M | — |
| Free Cash Flow | -$24.8M | -47.0% |
| -1427.5% |